Regulation of blood pressure, oxidative stress and AT1R by high salt diet in mutant human dopamine D5 receptor transgenic mice

Hypertension Research

Volumn 38, Issue 6, 2015, Pages 394-399

  Liu, Xing ^a   Wang, Wenjie ^a   Chen, Wei ^a   Jiang, Xiaoliang ^a   Zhang, Yanrong ^a   Wang, Zihao ^a   Yang, Jian ^b   Jones, John E ^b   Jose, Pedro A ^b   Yang, Zhiwei ^a  

^a INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

AT1R; D5R; NADPH oxidase; salt sensitive hypertension

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; COMPLEMENTARY DNA; CYCLIC AMP; DOPAMINE 5 RECEPTOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SALT INTAKE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CHO CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSFECTION; HIGH SALT DIET; HUMAN; HYPERTENSION; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; OXIDATIVE STRESS; SALT INTAKE; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; BLOOD PRESSURE; CRICETULUS; GENETICS; KIDNEY; METABOLISM; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; BLOOD PRESSURE; CHO CELLS; CRICETULUS; HYPERTENSION; KIDNEY; MICE; MICE, TRANSGENIC; NADP; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, DOPAMINE D5; SODIUM CHLORIDE, DIETARY;

EID: 84930508739     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2015.17     Document Type: Article

References (45)

1. Basson J, Simino J, Rao DC. Between candidate genes and whole genomes: time for alternative approaches in blood pressure genetics. Curr Hypertens Rep 2012; 14: 46-61.
2. Asghar M, Tayebati SK, Lokhandwala MF, Hussain T. Potential dopamine-1 receptor stimulation in hypertension management. Curr Hypertens Rep 2011; 13: 294-302.
3. Whelton PK, Appel LJ, Sacco RL, Anderson CA, Antman EM, Campbell N, Dunbar SB, Frohlich ED, Hall JE, Jessup M, Labarthe DR, MacGregor GA, Sacks FM, Stamler J, Vafiadis DK, Van Horn LV. Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation 2012; 126: 2880-2889.
4. Okamura DM, Himmelfarb J. Tipping the redox balance of oxidative stress in fibrogenic pathways in chronic kidney disease. Pediatr Nephrol 2009; 24: 2309-2319.
5. Jaimes EA, Zhou MS, Pearse DD, Puzis L, Raij L. Upregulation of cortical COX-2 in saltsensitive hypertension: role of angiotensin II and reactive oxygen species. Am J Physiol Renal Physiol 2008; 294: F385-F392.
6. Geiszt M, Kopp JB, Varnai P, Leto TL. Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci USA 2000; 97: 8010-8014.
7. Montezano AC, Touyz RM. Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies. Ann Med 2012; 44: S2-S16.
8. Ueda A, Ozono R, Oshima T, Yano A, Kambe M, Teranishi Y, Katsuki M, Chayama K. Disruption of the type 2 dopamine receptor gene causes a sodium-dependent increase in blood pressure in mice. Am J Hypertens 2003; 16: 853-858.
9. Johnson TL, Tulis DA, Keeler BE, Virag JA, Lust RM, Clemens S. The dopamine D3 receptor knockout mouse mimics aging-related changes in autonomic function and cardiac fibrosis. PLoS One 2013; 8: e74116.
10. Yang Z, Zheng S, Asico LD, Yu P, Bek M, Sibley DR, Jose PA. Increased PLD activity and elevated blood pressure in D5 receptor knockout mice. Am J Physiol Heart Circ Physiol 2005; 288: H55-H61.
11. Yang Z, Asico LD, Yu P, Wang Z, Jones JE, Escano CS, Wang X, Quinn MT, Sibley DR, Romero GG, Felder RA, Jose PA. D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol 2006; 290: R96-R104.
12. Allayee H, de Bruin TW, Michelle Dominguez K, Cheng LS, Ipp E, Cantor RM, Krass KL et al. Genome scan for blood pressure in Dutch dyslipidemic families reveals linkage to a locus on chromosome 4p. Hypertension 2001; 38: 773-778.
13. Grandy DK, Allen LJ, Zhang Y, Magenis RE, Civelli O. Chromosomal localization of three human D5 dopamine receptor genes. Genomics 1992; 13: 968-973.
14. Cooper RS, Luke A, Zhu X, Kan D, Adeyemo A, Rotimi C, Bouzekri N, Ward R, Rorimi C. Genome scan among Nigerians linking blood pressure to chromosomes 2, 3, and 19. Hypertension 2002; 40: 629-633.
15. Cravchik A, Gejman PV. Functional analysis of the human D5 dopamine receptor missense and nonsense variants: differences in dopamine binding affinities. Pharmacogenetics 1999; 9: 199-206.
16. Jose PA, Soares-da-Silva P, Eisner GM, Felder RA. Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation. Biochim Biophys Acta 2010; 1802: 1259-1267.
17. Zhang MZ, Yao B, Wang S, Fan X, Wu G, Yang H, Yin H, Yang S, Harris RC. Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice. J Clin Invest 2011; 121: 2845-2854.
18. Aperia A, Bertorello A, Seri I. Dopamine causes inhibition of Na-K-ATPase activity in rat proximal convoluted tubule segments. Am J Physiol Renal Fluid Electrolyte Physiol 1987; 252: F39-F45.
19. Bacic D, Kaissling B, McLeroy P, Zou L, Baum M, Moe OW. Dopamine acutely decreases apical membrane Na/H exchanger NHE3 protein in mouse renal proximal tubule. Kidney Int 2003; 64: 2133-2141.
20. Grider JS, Ott CE, Jackson BA. Dopamine D1 receptor-dependent inhibition of NaCl transport in the rat thick ascending limb: Mechanism of action. Eur J Pharmacol 2003; 473: 185-190.
21. Pedrosa R, Jose PA, Soares-Da-Silva P. Defective D1-like receptor-mediated inhibition of Cl-/HCO3-exchanger in immortalized SHR proximal tubular epithelial cells. Am J Physiol Renal Physiol 2004; 286: F1120-F1126.
22. Zeng C, Yang Z, Wang Z, Jones J, Wang X, Altea J, Mangrum AJ, Hopfer U, Sibley DR, Eisner GM, Felder RA, Jose PA. Interaction of angiotensin II type 1 and D5 dopamine receptors in renal proximal tubule cells. Hypertension 2005; 45: 804-810.
23. Li H, Armando I, Yu P, Escano C, Mueller SC, Asico L, Pascua A, Lu Q, Wang X, Villar VA, Jones JE, Wang Z, Periasamy A, Lau YS, Soares-da-Silva P, Creswell K, Guillemette G, Sibley DR, Eisner G, Gildea JJ, Felder RA, Jose PA. Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells. J Clin Invest 2008; 118: 2180-2189.
24. Kinoshita S, Sidhu A, Felder FA. Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. J Clin Invest 1989; 84: 1849-1856.
25. Mori T, Ogawa S, Cowely AW Jr, Ito S. Role of renal medullary oxidative and/or carbonyl stress in salt-sensitive hypertension and diabetes. Clin Exp Pharmacol Physiol 2012; 39: 125-131.
26. Ando K, Fujita M. Reactive oxygen species and the central nervous system in salt-sensitive hypertension: possible relationship with obesity-induced hypertension. Clin Exp Pharmacol Physiol 2012; 39: 111-116.
27. Manning RD Jr, Tian N, Meng S. Oxidative stress and antioxidant treatment in hypertension and the associated renal damage. Am J Nephrol 2005; 25: 311-317.
28. Varela M, Herrera M, Garvin JL. Inhibition of Na-K-ATPase in thick ascending limbs by NO depends on O2-and is diminished by a high-salt diet. Am J Physiol Renal Physiol 2004; 287: F224-F230.
29. Wilcox CS. Redox regulation of the afferent arteriole and tubuloglomerular feedback. Acta Physiol Scand 2003; 179: 217-223.
30. Banday AA, Muhammad AB, Fazili FR, Lokhandwala M. Mechanisms of oxidative stress-induced increase in salt sensitivity and development of hypertension in Sprague-Dawley rats. Hypertension 2007; 49: 664-671.
31. Kourie JI. Interaction of reactive oxygen species with ion transport mechanisms. Am J Physiol 1998; 275: C1-24.
32. Kim YH, Hwang JH, Noh JR, Gang GT, Tadi S, Yim YH, Jeoung NH, Kwak TH, Lee SH, Kweon GR, Kim JM, Shong M, Lee IK, Lee CH. Prevention of salt-induced renal injury by activation of NAD(P)H:quinone oxidoreductase 1, associated with NADPH oxidase. Free Radic Biol Med 2012; 52: 880-888.
33. Kitiyakara C, Chabrashvili T, Chen Y, Blau J, Karber A, Aslam S, Welch WJ, Wilcox CS. Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol 2003; 14: 2775-2782.
34. Lu Q, Yang Y, Villar VA, Asico L, Jones JE, Yu P, Li H, Weinman EJ, Eisner GM, Jose PA. D5 dopamine receptor decreases NADPH oxidase, reactive oxygen species and blood pressure via heme oxygenase-1. Hypertens Res 2013; 36: 684-690.
35. Yang Y, Zhang Y, Cuevas S, Villar VA, Escano C, Asico D, Yu L, Grandy P, Felder DK, Armando RA, Jose I, Paraoxonase PA. 2 decreases renal reactive oxygen species production, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of NADPH oxidase. Free Radic Biol Med 2012; 53: 437-446.
36. Cuevas S, Villar VA, Jose PA, Armando I. Renal dopamine receptors, oxidative stress, and hypertension. Int J Mol Sci 2013; 14: 17553-17572.
37. Crowley SD, Coffman TM. Recent advances involving the renin-angiotensin system. Exp Cell Res 2012; 318: 1049-1056.
38. Navar LG, Prieto MC, Satou R, Kobori H. Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension. Curr Opin Pharmacol 2011; 11: 180-186.
39. Zhang GX, Lu XM, Kimura S, Nishiyama A. Role of mitochondria in angiotensin IIinduced reactive oxygen species and mitogen-activated protein kinase activation. Cardiovasc Res 2007; 76: 204-212.
40. Yamamoto E, Tamamaki N, Nakamura T, Kataoka K, Tokutomi Y, Dong YF, Fukuda M, Matsuba S, Ogawa H, Kim-Mitsuyama S. Excess salt causes cerebral neuronal apoptosis and inflammation in stroke-prone hypertensive rats through angiotensin II-induced NADPH oxidase activation. Stroke 2008; 39: 3049-3056.
41. Gao L, Wang W, Li YL, Schultz HD, Liu D, Cornish KG, Zucker IH. Superoxide mediates sympathoexcitation in heart failure: roles of angiotensin II and NAD(P)H oxidase. Circ Res 2004; 95: 937-944.
42. Zeng C, Wang Z, Hopfer U, Asico LD, Eisner GM, Felder RA, Jose PA. Rat strain effects of AT1 receptor activation on D1 dopamine receptors in immortalized renal proximal tubule cells. Hypertension 2005; 46: 799-805.
43. Chugh G, Lokhandwala MF, Asghar M. Altered functioning of both renal dopamine D1 and angiotensin II type 1 receptors causes hypertension in old rats. Hypertension 2012; 59: 1029-1036.
44. Yang S, Yao B, Zhou Y, Yin H, Zhang MZ, Harris RC. Intrarenal dopamine modulates progressive angiotensin II-mediated renal injury. Am J Physiol Renal Physiol 2012; 302: F742-F749.
45. Li D, Scott L, Crambert S, Zelenin S, Eklöf AC, Di Ciano L, Ibarra F, Aperia A. Binding of losartan to angiotensin AT1 receptors increases dopamine D1 receptor activation. J Am Soc Nephrol 2012; 23: 421-428.